CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 03/31/2014

Position Statistics

Total Positions 58
New Positions 20
Increased Positions 34
Decreased Positions 18
Positions with Activity 52
Sold Out Positions 11
Total Mkt Value (in $ millions) 451

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 5.42%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 82.7%
Services
Technology
Transportation
Utilities

18 DECREASED Positions as of 03/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
IDENIX PHARMACEUTICALS INC COM 60,800 -10,336 (14.53) 2,500,000
CUBIST PHARMACEUTICALS INC COM 18,420 -6,140 (25) 300,000
DYAX CORP COM 17,100 -7,268 (29.83) 2,000,000
ACADIA PHARMACEUTICALS COM 6,078 -10,130 (62.5) 300,000
GERON CORP COM 3,585 -4,534 (55.85) 1,500,000
ALNYLAM PHARMACEUTICALS INC COM 2,666 -10,662 (80) 50,000
ASTERIAS BIOTHERAPEUTICS INC COM SER A 129 -164 (55.85) 62,490
AMAG PHARMACEUTICALS INC COM -4,485 Sold Out 0
BRISTOL MYERS SQUIBB CO COM -13,446 Sold Out 0
CELGENE CORP COM -21,034 Sold Out 0
DENDREON CORP COM -314 Sold Out 0
ENANTA PHARMACEUTICALS INC COM -387 Sold Out 0
FIVE PRIME THERAPEUTICS INC COM -246 Sold Out 0
INSULET CORP COM -5,408 Sold Out 0
KERYX BIOPHARMACEUTICALS INC COM -25,500 Sold Out 0
MOMENTA PHARMACEUTICALS INC COM -295 Sold Out 0
OSIRIS THERAPEUTICS INC NEW COM -1,563 Sold Out 0
XENOPORT INC COM -830 Sold Out 0